Baptist Health, Louisville
6
2
2
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 6 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
50%
1 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
ROSE-Longitudinal Assessment With Neuroimaging
Role: collaborator
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
Role: collaborator
Recovery and Outcomes From Stroke
Role: collaborator
Study of Management Alterations Resulting From CaRi-Heart® Technology in Patients Undergoing Coronary Computed Tomography Angiography (CCTA) for the Evaluation of Coronary Artery Disease: A United States Based Multi-Centre Study (SMART-CCTA-1)
Role: collaborator
His Bundle Pacing Versus Coronary Sinus Pacing for Cardiac Resynchronization Therapy
Role: collaborator
A Phase I Study Evaluating the Safety of Stereotactic Central Ablative Radiation Therapy (SCART) for Bulky Metastatic or Recurrent Cancer
Role: lead
All 6 trials loaded